Carbapenem resistance via the blaKPC-2 gene in enterobacter cloacae blood culture isolate

Southern Medical Journal

Volumn 103, Issue 5, 2010, Pages 453-454

  Lo, Andy ^a   Verrall, Rosemary ^a   Williams, John ^a   Stratton, Charles ^a   Della Latta, Phyllis ^a   Tang, Yi Wei ^a  

^a NONE

Author keywords

Enterobacter cloacae; Klebsiella pneumoniae carbapenemase

Indexed keywords

AMIKACIN; CARBAPENEM; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BLOOD CULTURE; CASE REPORT; CHILD; DIAPER DERMATITIS; DIARRHEA; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; PRESCHOOL CHILD; SEIZURE; TACHYCARDIA; UNITED STATES;

BETA-LACTAM RESISTANCE; BLOOD; CARBAPENEMS; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTER CLOACAE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE;

EID: 77951827735     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181d710bf     Document Type: Article

References (12)

1. Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 2000;6:460-463.
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-236.
3. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-1161. (Pubitemid 32230996)
4. Tibbetts R, Frye JG, Marschall J, et al. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis. J Clin Microbiol 2008;46:3080-3083.
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Tenth Edition. Wayne, PA, Clinical and Laboratory Standards Institute, 2008.
6. Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91. (Pubitemid 34960278)
7. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-458.
8. Deshpande LM, Rhomberg PR, Sader HS, et al. Emergence of serine car-bapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis 2006;56:367-372.
9. Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother 2007;60:470-482. (Pubitemid 47299859)
10. Gootz TD, Lescoe MK, Dib-Hajj F, et al. Genetic organization of trans-posase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother 2009;53:1998-2004.
11. Villegas MV, Lolans K, Correa A, et al; Colombian Nosocomial Resistance Study Group. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother 2007;51:1553-1555. (Pubitemid 46586851)
12. Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing En-terobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256-260.